Scotts Miracle-Gro is an Ohio-based company mostly known for its garden products and fertilizers. The company was recently featured in a Bloomberg article discussing the company’s foray into the cannabis space, and the work that it is doing with the Flowr Corporation. Scotts Miracle-Gro’s subsidiary, Hawthorne Gardening Co., has partnered with Flowr to build a 50,000-square-foot research and development facility in Kelowna, British Columbia. Their research will be aimed at testing the effects Hawthorne’s lights and nutrients have on cannabis and will hopefully include the genetic testing on cannabis and the effect it has on a human’s physiology.

“They know all of the big players, and they chose our team because of their faith in us to grow consistent product,” said incoming Flowr CEO Vinay Tolia.

Alongside Tolia, Flowr is also endowed by other industry experts including president and co-founder Tom Flow, who also co-founded MedReleaf Corp. Flowr is already able to produce 250 grams per square foot of cannabis and is aiming to produce 450 grams per square foot in the future, well above the industry average of approximately 100 grams per square foot. Flowr is also capable of distributing their products having signed pre-legalization agreements with the Ontario and British Columbian governments, a distribution agreement in Germany and is looking for opportunities in the Caribbean and South America.

To read the full article, click here.

Click here to connect with the Flowr Corporation for an Investors Deck.

Subsequent to this press release, The Flowr Corporation went public on September 26, 2018 under the ticker symbol TSXV:FLWR.



Avicanna Inc. (the “ Company ” or “ Avicanna ”) (TSX: AVCN) announced today that it has been issued a Cease Trade Order (“ CTO ”) by the Ontario Securities Commission (the “ OSC ”) as it no longer expects to file the following periodic disclosure documents (collectively, the “ Documents ”) by June 11, 2021, as previously disclosed:

Keep reading... Show less

Adds two accomplished female directors to the Board

Trulieve Cannabis Corp. (“Trulieve” or the “Company”) (CSE: TRUL) (OTCQX: TCNNF), a leading and top-performing cannabis company in the United States today announced the results of its Annual and Special Meeting of Shareholders held on June 10, 2021 (the “Meeting”). Each of the eight individuals nominated for election as a director of Trulieve at the Meeting were elected, including new nominees, Giannella Alvarez and Jane Morreau .

Keep reading... Show less

The National Football League (NFL) wants to know more about cannabis as a pain reliever, and it’s willing to put up an initial US$1 million for research.

Also this week, a cannabis operator announced plans to buy assets from a languishing producer.

Keep reading... Show less

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today the opening of a new Florida dispensary, the Company’s 89th nationwide.

The dispensary will be located next to the Citrus Park Town Center and helps meet Trulieve’s goal of ensuring medical cannabis patients across Florida have safe, reliable access to the medications they rely on. The facility joins four other Tampa dispensaries, as well as several more in nearby Clearwater , St. Petersburg , and Largo.

Keep reading... Show less

On June 10, 2021, RCP23, LLC (the “Seller”), a private investment holding company controlled by Benjamin Kovler, CEO and Chairman of Green Thumb Industries Inc. (the “Issuer”) (CSE: GTII) (OTCQX: GTBIF), sold 1,666,667 Subordinate Voting Shares of the Issuer (the “Transferred Shares”) to a third-party qualified institutional buyer at a purchase price of US$30.00 per share in a private transaction.

“This transaction brings Green Thumb a new institutional shareholder who is aligned with management’s long-term vision,” said Manager of RCP23 Benjamin Kovler.  “RCP23 has historically sold shares on behalf of our legacy shareholders who invested prior to Green Thumb going public.”

Keep reading... Show less